Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Wild Type p53 Adenovirus for Oral Premalignancies

This study has been terminated.
(Sponsor withdrawl prior to study completion.)
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Department of Health and Human Services
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00410865
First received: December 11, 2006
Last updated: December 6, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2010
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)